Search papers, labs, and topics across Lattice.
This study introduces MSCNet, a sequence-conditioned cross-modal generative model designed to reconstruct missing contrasts and restore degraded prostate MRI sequences. The model demonstrated superior performance in structural similarity and lesion fidelity compared to existing methods, achieving a mean structural similarity index of 0.818 in ten completion tasks. In clinical validation, MSCNet met non-inferiority criteria for overall image quality in several MRI sequences and showed promising diagnostic capability for clinically significant cancer across multiple centers.
MSCNet not only reconstructs missing MRI sequences but also enhances lesion fidelity, outperforming traditional methods in clinical settings.
Missing or degraded sequences can limit prostate multiparametric MRI. We developed MSCNet, a sequence-conditioned cross-modal generative framework for reconstructing unavailable contrasts and restoring degraded acquisitions. Across ten completion tasks, task-specific MSCNet achieved mean structural similarity of 0.818 versus 0.798 for the strongest task-matched comparators; matched-capacity analyses showed larger differences in lesion fidelity and boundary preservation. In a blinded 1,000-case reader study, overall image quality met the prespecified non-inferiority criterion for DWI, ADC and T2W completion, but not T1W. In a separate 200-case diagnostic assessment, AUCs for clinically significant cancer were 0.860 with acquired images, 0.841 with MSCNet and 0.797 with baseline-generated images. A locked 186-case three-hospital cohort supported multicentre transportability. These retrospective results support quality-controlled cross-modal reconstruction as an adjunct to acquired prostate MRI.